Binding of active (57 kDa) membrane type 1-matrix metalloproteinase (MT1-MMP) to tissue inhibitor of metalloproteinase (TIMP)-2 regulates MT1-MMP processing and pro-MMP-2 activation

被引:275
作者
Hernandez-Barrantes, S
Toth, M
Bernardo, MM
Yurkova, M
Gervasi, DC
Raz, Y
Sang, QXA
Fridman, R
机构
[1] Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA
[2] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA
[3] Florida State Univ, Dept Chem, Div Biochem, Tallahassee, FL 32306 USA
关键词
D O I
10.1074/jbc.275.16.12080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous studies have shown that membrane type 1-matrix metalloproteinase (MT1-MMP) (MMP-14) initiates pro-MMP-2 activation in a process that is tightly regulated by the level of tissue inhibitor of metalloproteinase (TIMP)-2. However, given the difficulty in modulating TIMP-2 levels, the direct effect of TIMP-2 on MT1-MMP processing and on pro-MMP-2 activation in a cellular system could not be established. Here, recombinant vaccinia viruses encoding full-length MT1-MMP or TIMP-2 were used to express MT1-MMP alone or in combination with various levels of TIMP-2 in mammalian cells. We show that TIMP-2 regulates the amount of active MT1-MMP (57 kDa) on the cell surface whereas in the absence of TIMP-2 MT1-MMP undergoes autocatalysis to a 44-kDa form, which displays a N terminus starting at Gly(285) and hence lacks the entire catalytic domain. Neither pro-MT1-MMP (N terminus Ser(24)) nor the 44-kDa form bound TIMP-2. In contrast, active MT1-MMP (N terminus Tyr(112)) formed a complex with TIMP-2 suggesting that regulation of MT1-MMP processing is mediated by a complex of TIMP-2 with the active enzyme. Consistently, TIMP-2 enhanced the activation of pro-MMP-2 by MT1-MMP. Thus, under controlled conditions, TIMP-2 may act as a positive regulator of MT1-MMP activity by promoting the availability of active MT1-MMP on the cell surface and consequently, may support pericellular proteolysis.
引用
收藏
页码:12080 / 12089
页数:10
相关论文
共 50 条
[1]   MATRIX METALLOPROTEINASES - A REVIEW [J].
BIRKEDALHANSEN, H ;
MOORE, WGI ;
BODDEN, MK ;
WINDSOR, LJ ;
BIRKEDALHANSEN, B ;
DECARLO, A ;
ENGLER, JA .
CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) :197-250
[2]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[3]   The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A - A kinetic study [J].
Butler, GS ;
Butler, MJ ;
Atkinson, SJ ;
Will, H ;
Tamura, T ;
van Westrum, SS ;
Crabbe, T ;
Clements, J ;
d'Ortho, MP ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) :871-880
[4]   The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A [J].
Cao, J ;
Drews, M ;
Lee, HM ;
Conner, C ;
Bahou, WF ;
Zucker, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (52) :34745-34752
[5]   Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain [J].
Cao, JA ;
Rehemtulla, A ;
Bahou, W ;
Zucker, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (47) :30174-30180
[6]   MT1-MMP on the cell surface causes focal degradation of gelatin films [J].
d'Ortho, MP ;
Stanton, H ;
Butler, M ;
Atkinson, SJ ;
Murphy, G ;
Hembry, RM .
FEBS LETTERS, 1998, 421 (02) :159-164
[7]   Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases [J].
d'Ortho, MP ;
Will, H ;
Atkinson, S ;
Butler, G ;
Messent, A ;
Gavrilovic, J ;
Smith, B ;
Timpl, R ;
Zardi, L ;
Murphy, G .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 250 (03) :751-757
[8]  
Ellerbroek SM, 1999, CANCER RES, V59, P1635
[9]   CAP-INDEPENDENT TRANSLATION OF MESSENGER-RNA CONFERRED BY ENCEPHALOMYOCARDITIS VIRUS 5' SEQUENCE IMPROVES THE PERFORMANCE OF THE VACCINIA VIRUS BACTERIOPHAGE-T7 HYBRID EXPRESSION SYSTEM [J].
ELROYSTEIN, O ;
FUERST, TR ;
MOSS, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (16) :6126-6130
[10]   Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor [J].
Fernandez-Catalan, C ;
Bode, W ;
Huber, R ;
Turk, D ;
Calvete, JJ ;
Lichte, A ;
Tschesche, H ;
Maskos, K .
EMBO JOURNAL, 1998, 17 (17) :5238-5248